InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+86.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Galovan Scott Michael, Chief Financial Officer. Insider active across 1 company, notably Avanos Medical, INC.. Cumulatively, 9 reports have been published. Activity tracked since 6 March 2026. The latest transaction was filed on 13 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
29,481 shares0Common StockSEC:0001606498-26-000040:0
29,481 shares0Common StockSEC:0001606498-26-000040
29,481 shares0Common StockSEC:0001606498-26-000031
29,481 shares0Common StockSEC:0001606498-26-000031:0
29,481 shares0Common StockSEC:0001606498-26-000027:0
5,907 shares@ US$13.790.0061% mcap52.0% of flowCommon StockSEC:0001606498-26-000010:0
2,356 shares@ US$13.790.0024% mcap20.7% of flowCommon StockSEC:0001606498-26-000010:1
1,057 shares@ US$13.790.0011% mcap9.3% of flowCommon StockSEC:0001606498-26-000010:2
2,041 shares@ US$13.790.0021% mcap18.0% of flowCommon StockSEC:0001606498-26-000010:3
9 of 9 declarations
About Galovan Scott Michael
Scott Michael Galovan is Chief Financial Officer at Avanos Medical, Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. With a strong background in corporate finance, Scott plays a key role in financial strategy and decision-making. His expertise is essential in ensuring the financial health of Avanos Medical, Inc.
